Wealth Dimensions Group Ltd. Boosts Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Wealth Dimensions Group Ltd. lifted its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 3.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 892 shares of the healthcare conglomerate’s stock after buying an additional 31 shares during the quarter. Wealth Dimensions Group Ltd.’s holdings in UnitedHealth Group were worth $473,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of the business. Simplify Asset Management Inc. increased its stake in UnitedHealth Group by 8.8% in the fourth quarter. Simplify Asset Management Inc. now owns 7,997 shares of the healthcare conglomerate’s stock valued at $4,240,000 after purchasing an additional 644 shares during the last quarter. J.Safra Asset Management Corp increased its stake in UnitedHealth Group by 88.8% in the fourth quarter. J.Safra Asset Management Corp now owns 389 shares of the healthcare conglomerate’s stock valued at $206,000 after purchasing an additional 183 shares during the last quarter. Wade G W & Inc. increased its stake in UnitedHealth Group by 8.7% during the fourth quarter. Wade G W & Inc. now owns 10,385 shares of the healthcare conglomerate’s stock worth $5,506,000 after acquiring an additional 834 shares during the last quarter. Giverny Capital Inc. acquired a new stake in UnitedHealth Group during the fourth quarter worth about $919,000. Finally, Colonial River Wealth Management LLC increased its stake in UnitedHealth Group by 7.2% during the fourth quarter. Colonial River Wealth Management LLC now owns 2,415 shares of the healthcare conglomerate’s stock worth $1,280,000 after acquiring an additional 163 shares during the last quarter. 86.31% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In related news, CEO Andrew Witty sold 6,160 shares of the company’s stock in a transaction on Thursday, April 27th. The shares were sold at an average price of $487.49, for a total value of $3,002,938.40. Following the completion of the sale, the chief executive officer now owns 86,564 shares in the company, valued at approximately $42,199,084.36. The transaction was disclosed in a filing with the SEC, which is available through this link. In other news, CEO Andrew Witty sold 6,160 shares of the firm’s stock in a transaction dated Thursday, April 27th. The stock was sold at an average price of $487.49, for a total value of $3,002,938.40. Following the completion of the transaction, the chief executive officer now owns 86,564 shares in the company, valued at approximately $42,199,084.36. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Erin Mcsweeney sold 1,684 shares of the firm’s stock in a transaction dated Monday, April 24th. The shares were sold at an average price of $488.46, for a total value of $822,566.64. Following the completion of the transaction, the executive vice president now owns 8,675 shares of the company’s stock, valued at approximately $4,237,390.50. The disclosure for this sale can be found here. Insiders have sold a total of 8,852 shares of company stock valued at $4,313,962 in the last 90 days. 0.35% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on UNH shares. Loop Capital upped their target price on UnitedHealth Group from $590.00 to $600.00 and gave the stock a “buy” rating in a research report on Monday, April 17th. StockNews.com started coverage on UnitedHealth Group in a research note on Thursday, May 18th. They set a “strong-buy” rating on the stock. Raymond James reiterated a “strong-buy” rating and set a $630.00 price target on shares of UnitedHealth Group in a research report on Friday, April 14th. Oppenheimer reaffirmed an “outperform” rating and set a $610.00 target price on shares of UnitedHealth Group in a research note on Monday, April 17th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and set a $592.00 target price on shares of UnitedHealth Group in a research note on Monday, April 17th. Two research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus price target of $599.00.

UnitedHealth Group Stock Up 0.5 %

Shares of NYSE:UNH traded up $2.52 on Friday, reaching $480.22. The company had a trading volume of 1,394,197 shares, compared to its average volume of 3,305,406. UnitedHealth Group Incorporated has a twelve month low of $449.70 and a twelve month high of $558.10. The stock has a market capitalization of $447.10 billion, a P/E ratio of 21.84, a P/E/G ratio of 1.39 and a beta of 0.68. The stock has a 50-day moving average price of $489.68 and a 200 day moving average price of $499.78. The company has a quick ratio of 0.81, a current ratio of 0.81 and a debt-to-equity ratio of 0.71.

UnitedHealth Group (NYSE:UNH – Get Rating) last released its quarterly earnings data on Friday, April 14th. The healthcare conglomerate reported $6.26 earnings per share for the quarter, beating the consensus estimate of $6.24 by $0.02. UnitedHealth Group had a return on equity of 27.05% and a net margin of 6.16%. The company had revenue of $91.93 billion for the quarter, compared to analyst estimates of $89.77 billion. During the same period in the prior year, the company posted $5.49 EPS. The company’s revenue was up 14.7% compared to the same quarter last year. On average, equities analysts expect that UnitedHealth Group Incorporated will post 24.98 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 21st. Stockholders of record on Monday, March 13th were paid a $1.65 dividend. This represents a $6.60 dividend on an annualized basis and a dividend yield of 1.37%. The ex-dividend date of this dividend was Friday, March 10th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 30.18%.

UnitedHealth Group Company Profile

(Get Rating)

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.